Clinical trials: Flutter, Atrial

Anticoagulation, Atrial Fibrillation

AntiCoagulation Tracking InterVention and Evaluation

• Withdrawn
• Age: 18 to 99 years

Anticoagulants are a leading cause of acute injury from adverse drug events, leading to ~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency department visits annually.

Conditions

Anticoagulation, Atrial Fibrillation, Atrial Flutter, Pulmonary Embolus/Emboli

Trial name

ACTIVE (NCT04059965)

Testing

Panel Management for Anticoagulation Therapy, Usual Care

Volunteers

healthy volunteers welcome

Sponsor

University of California, San Francisco